Literature DB >> 7815658

Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993.

J A Milberg1, D R Davis, K P Steinberg, L D Hudson.   

Abstract

OBJECTIVE: To analyze temporal trends in acute respiratory distress syndrome (ARDS) fatality rates since 1983 at one institution.
DESIGN: Cohort.
SETTING: Intensive care units of a large county hospital. PATIENTS: Consecutive adult patients (> or = 18 years of age) meeting ARDS criteria were identified through daily surveillance of intensive care units (N = 918 from 1983 through 1993). The major causes were sepsis syndrome in 37% and major trauma in 25%; 37% had other risks. Sixty-five percent were male. The median age was 45 years (range, 18 to 92 years); 70% were younger than 60 years. MAIN OUTCOME MEASURE: Hospital mortality.
RESULTS: Overall fatality rates showed no trend from 1983 to 1987, declined slightly in 1988 and 1989, and decreased to a low of 36% in 1993 (95% confidence interval, 25% to 46%). The crude rates were largely unchanged after adjustment for age, ARDS risk, and gender distribution. While patients both younger than 60 years and 60 years or older experienced declines in fatality rate, the larger decrease occurred in the younger cohort. In sepsis patients, ARDS fatality rates declined steadily, from 67% in 1990 to 40% in 1993 (95% confidence interval, 23% to 57%). The decline in sepsis-related ARDS fatality was confined largely to patients less than 60 years of age. Trauma patients and all other patients also experienced declines in fatality rates after 1987, although these trends were not as strong and consistent as in the sepsis population.
CONCLUSIONS: In this large series, we observed a significant decrease in fatality rates occurring largely in patients younger than 60 years and in those with sepsis syndrome as their risk for ARDS. We are unable to determine the extent to which experimental therapies or other changes in treatment have contributed to the observed decline in the ARDS fatality rate. Institution-specific rates and temporal trends in ARDS fatality rates should be considered in clinical trials designed to prevent ARDS and the high mortality associated with this syndrome.

Entities:  

Mesh:

Year:  1995        PMID: 7815658

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  103 in total

Review 1.  Ventilator-associated systemic inflammation in acute lung injury.

Authors:  C Putensen; H Wrigge
Journal:  Intensive Care Med       Date:  2000-10       Impact factor: 17.440

Review 2.  Recent advances: recent advances in intensive care.

Authors:  S Stott
Journal:  BMJ       Date:  2000-02-05

3.  Improving survival in trauma patients with acute respiratory distress syndrome.

Authors:  U Kaisers; T Busch
Journal:  Intensive Care Med       Date:  2001-07       Impact factor: 17.440

Review 4.  Ventilator induced lung injury and infection in the critically ill.

Authors:  S V Baudouin
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

Review 5.  The pulmonary physician in critical care * 6: The pathogenesis of ALI/ARDS.

Authors:  G J Bellingan
Journal:  Thorax       Date:  2002-06       Impact factor: 9.139

6.  Health status after critical illness: beyond descriptive studies.

Authors:  Gordon D Rubenfeld; J Randall Curtis
Journal:  Intensive Care Med       Date:  2003-10       Impact factor: 17.440

7.  Hot new therapy for sepsis and the acute respiratory distress syndrome.

Authors:  Arthur S Slutsky
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

8.  Adenoviral transfer of HSP-70 into pulmonary epithelium ameliorates experimental acute respiratory distress syndrome.

Authors:  Yoram G Weiss; Alina Maloyan; John Tazelaar; Nichelle Raj; Clifford S Deutschman
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

Review 9.  The pulmonary physician in critical care. 8: Ventilatory management of ALI/ARDS.

Authors:  J J Cordingley; B F Keogh
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

10.  Chronic Pancreatitis Associated Acute Respiratory Failure.

Authors:  Murli Manohar; Alok K Verma; Sathisha Upparahalli Venkateshaiah; Nathan L Sanders; Anil Mishra
Journal:  MOJ Immunol       Date:  2017-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.